4//SEC Filing
Poradosu Enrique 4
Accession 0001104659-22-060908
CIK 0001875558other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:31 AM ET
Size
7.6 KB
Accession
0001104659-22-060908
Insider Transaction Report
Form 4
Poradosu Enrique
Chief Science & Business Off
Transactions
- Purchase
Common Stock
2022-05-12$14.76/sh+370$5,461→ 1,258,019 total - Purchase
Common Stock
2022-05-12$16.04/sh+300$4,812→ 1,258,319 total
Footnotes (3)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.60 to $15.05. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.
- [F3]Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.99 to $16.08. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001898147
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:31 AM ET
- Size
- 7.6 KB